Viewing data from:

CILOSTAZOL

ANDA

CILOSTAZOL | A077021 | CHARTWELL RX SCIENCES LLC

1 strength0 unique patents0 unique exclusivities

API Supply Chain7 active DMFs6 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

WAVELENGTH ENTERPRISES LTDCILOSTAZOL

DMF 166452003

TAPI NL BVCILOSTAZOL USP

DMF 167222003

ALIVUS LIFE SCIENCES LTDCILOSTAZOL USP

DMF 168762003

DIPHARMA FRANCIS SRLCILOSTAZOL

DMF 170502003

CHONGQING KANGLE PHARMACEUTICAL CO LTDCILOSTAZOL USP (DRUG SUBSTANCE, NON-STERILE)

DMF 224632009

CHONGQING KANGLE PHARMACEUTICAL CO LTDCILOSTAZOL USP

DMF 256662011

COHANCE LIFESCIENCES LTDCILOSTAZOL

DMF 431812025

SA AJINOMOTO OMNICHEM NVInactiveCILOSTAZOL

DMF 173722004

ALEMBIC PHARMACEUTICALS LTDInactiveCILOSTAZOL

DMF 174752004

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)InactiveCILOSTAZOL

DMF 179732004

RANBAXY LABORATORIES LTDInactiveCILOSTAZOL DRUG SUBSTANCE

DMF 190762005

IPCA LABORATORIES LTDInactiveCILOSTAZOL USP

DMF 216782008

CHONGQING KANGLE PHARMACEUTICAL CO LTDInactiveCILOSTAZOL DRUG SUBSTANCE NON STERILE

DMF 226432008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 2, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 100MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 23, 2004

No patent or exclusivity listings for this strength.